State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, People's Republic of China.
Stem Cells. 2014 Aug;32(8):2278-89. doi: 10.1002/stem.1723.
Erythroid differentiation-associated gene (EDAG) has been considered to be a transcriptional regulator that controls hematopoietic cell differentiation, proliferation, and apoptosis. The role of EDAG in erythroid differentiation of primary erythroid progenitor cells and in vivo remains unknown. In this study, we found that EDAG is highly expressed in CMPs and MEPs and upregulated during the erythroid differentiation of CD34(+) cells following erythropoietin (EPO) treatment. Overexpression of EDAG induced erythroid differentiation of CD34(+) cells in vitro and in vivo using immunodeficient mice. Conversely, EDAG knockdown reduced erythroid differentiation in EPO-treated CD34(+) cells. Detailed mechanistic analysis suggested that EDAG forms complex with GATA1 and p300 and increases GATA1 acetylation and transcriptional activity by facilitating the interaction between GATA1 and p300. EDAG deletion mutants lacking the binding domain with GATA1 or p300 failed to enhance erythroid differentiation, suggesting that EDAG regulates erythroid differentiation partly through forming EDAG/GATA1/p300 complex. In the presence of the specific inhibitor of p300 acetyltransferase activity, C646, EDAG was unable to accelerate erythroid differentiation, indicating an involvement of p300 acetyltransferase activity in EDAG-induced erythroid differentiation. ChIP-PCR experiments confirmed that GATA1 and EDAG co-occupy GATA1-targeted genes in primary erythroid cells and in vivo. ChIP-seq was further performed to examine the global occupancy of EDAG during erythroid differentiation and a total of 7,133 enrichment peaks corresponding to 3,847 genes were identified. Merging EDAG ChIP-Seq and GATA1 ChIP-Seq datasets revealed that 782 genes overlapped. Microarray analysis suggested that EDAG knockdown selectively inhibits GATA1-activated target genes. These data provide novel insights into EDAG in regulation of erythroid differentiation.
红细胞分化相关基因 (EDAG) 被认为是一种转录调节因子,可控制造血细胞的分化、增殖和凋亡。EDAG 在原代红细胞祖细胞的红细胞分化和体内的作用尚不清楚。在这项研究中,我们发现 EDAG 在 CMP 和 MEPs 中高度表达,并在 EPO 处理后 CD34+细胞的红细胞分化过程中上调。EDAG 的过表达在体外和免疫缺陷小鼠体内诱导 CD34+细胞的红细胞分化。相反,EDAG 敲低减少了 EPO 处理的 CD34+细胞中的红细胞分化。详细的机制分析表明,EDAG 与 GATA1 和 p300 形成复合物,并通过促进 GATA1 和 p300 之间的相互作用增加 GATA1 乙酰化和转录活性。缺乏与 GATA1 或 p300 结合域的 EDAG 缺失突变体未能增强红细胞分化,表明 EDAG 通过形成 EDAG/GATA1/p300 复合物部分调节红细胞分化。在 p300 乙酰转移酶活性的特异性抑制剂 C646 的存在下,EDAG 无法加速红细胞分化,表明 p300 乙酰转移酶活性参与 EDAG 诱导的红细胞分化。ChIP-PCR 实验证实 GATA1 和 EDAG 在原代红细胞细胞和体内共同占据 GATA1 靶向基因。进一步进行 ChIP-seq 实验以检查 EDAG 在红细胞分化过程中的全局占据情况,共鉴定出 7133 个对应于 3847 个基因的富集峰。将 EDAG ChIP-Seq 和 GATA1 ChIP-Seq 数据集合并揭示了 782 个基因重叠。微阵列分析表明 EDAG 敲低选择性抑制 GATA1 激活的靶基因。这些数据为 EDAG 在红细胞分化调控中的作用提供了新的见解。